XML 17 R2.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
3 Months Ended 9 Months Ended
Mar. 30, 2025
Mar. 31, 2024
Mar. 30, 2025
Mar. 31, 2024
Income Statement [Abstract]        
Revenue $ 4,720,175,000 $ 3,793,558,000 $ 13,264,198,000 $ 11,033,879,000
Cost of goods sold 2,406,489,000 1,977,820,000 6,874,848,000 5,783,087,000
Restructuring charges, net - cost of goods sold 0 15,202,000 0 38,099,000
Total cost of goods sold 2,406,489,000 1,993,022,000 6,874,848,000 5,821,186,000
Gross margin 2,313,686,000 1,800,536,000 6,389,350,000 5,212,693,000
Research and development 525,904,000 512,274,000 1,516,209,000 1,404,615,000
Selling, general, and administrative 226,023,000 215,904,000 713,301,000 651,770,000
Restructuring charges, net - operating expenses 0 15,246,000 0 18,955,000
Total operating expenses 751,927,000 743,424,000 2,229,510,000 2,075,340,000
Operating income 1,561,759,000 1,057,112,000 4,159,840,000 3,137,353,000
Other income (expense), net (25,035,000) 36,073,000 19,308,000 68,513,000
Income before income taxes 1,536,724,000 1,093,185,000 4,179,148,000 3,205,866,000
Income tax expense (206,057,000) (127,359,000) (541,019,000) (398,376,000)
Net income $ 1,330,667,000 $ 965,826,000 $ 3,638,129,000 $ 2,807,490,000
Net income per share:        
Basic (in dollars per share) $ 1.04 $ 0.74 $ 2.82 $ 2.13
Diluted (in dollars per share) $ 1.03 $ 0.73 $ 2.81 $ 2.12
Number of shares used in per share calculations:        
Basic (in shares) 1,283,779 1,308,382 1,290,041 1,316,627
Diluted (in shares) 1,288,100 1,315,178 1,294,545 1,322,819